跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METFORMIN TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
METFORMIN TABLETS
Authorized
STANDARD
METFORMIN TABLETS
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4ad457a872c0d05d
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
4ad457a872c0d05d
Drug Approval Canada Name
METFORMIN TABLETS
Product Name
METFORMIN TABLETS
Status
Dormant
Status Date
2024-03-21
Original Market Date
2023-03-21
Din
02527669
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.04
Atc Original
A10BA02 METFORMIN
Atc Name
a 10 ba 02
Aig Number
0101773002
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
METFORMIN HYDROCHLORIDE
850 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4ad457a872c0d05d
Type
Standard
Back to Health Canada Approvals